AstraZeneca PLC (AZN)
NASDAQ: AZN · Real-Time Price · USD
72.83
+1.96 (2.77%)
At close: May 30, 2025, 4:00 PM
73.00
+0.17 (0.23%)
After-hours: May 30, 2025, 7:58 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| Oncology | 21.16B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oncology Growth | 17.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BioPharmaceuticals: CVRM | 12.69B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BioPharmaceuticals: CVRM Growth | 14.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BioPharmaceuticals: R&I | 7.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BioPharmaceuticals: R&I Growth | 21.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Medicines | 1.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Medicines Growth | -8.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| COVID-19 | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| COVID-19 Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Collaboration | 2.71B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Collaboration Growth | 22.43% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BioPharmaceuticals V&I | 1.07B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BioPharmaceuticals V&I Growth | 23.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rare Disease | 8.61B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rare Disease Growth | 7.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capex by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2011 - 2019 |
| UK Assets Acquired |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| UK Assets Acquired Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Assets Acquired |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Assets Acquired Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| The Americas Assets Acquired |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| The Americas Assets Acquired Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia, Africa & Australasia Assets Acquired |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia, Africa & Australasia Assets Acquired Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2011 - 2019 |
| UK Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| UK Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| The Americas Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| The Americas Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia, Africa & Australasia Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia, Africa & Australasia Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2011 - 2019 |
| UK Revenue |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| UK Revenue Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| The Americas |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| The Americas Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia, Africa & Australasia |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia, Africa & Australasia Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|